Status:
TERMINATED
Obstructive Sleep Apnea Syndrome in Glaucoma
Lead Sponsor:
Selim Orguel
Collaborating Sponsors:
University Hospital, Basel, Switzerland
Conditions:
Obstructive Sleep Apnea Syndrome
Glaucoma
Eligibility:
All Genders
18-95 years
Brief Summary
The aim of the study is to determine if plasma matrix-metalloproteinase activity can predict glaucoma in patients with OSAS and if the level of plasma matrix-metalloproteinase activity will decrease a...
Detailed Description
Glaucoma is a leading cause of blindness world-wide. Chronic primary open-angle glaucoma is the most common form among Caucasian patients. The key feature of glaucoma is damage to the optic nerve head...
Eligibility Criteria
Inclusion
- OSAS planned begin of a nCPAP treatment
Exclusion
- Current malignancy
- Oral steroids
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00313092
Start Date
January 1 2005
End Date
September 1 2005
Last Update
October 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel, Eye Clinic
Basel, Canton of Basel-City, Switzerland, 4031